131 related articles for article (PubMed ID: 3503035)
1. Digital and radial artery blood flow in patients with Raynaud's phenomenon in response to nifedipine.
Morgan RH; Psaila JV; Davies WT; Carolan G; Woodcock JP
Eur J Vasc Surg; 1987 Dec; 1(6):403-8. PubMed ID: 3503035
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.
Wise RA; Malamet R; Wigley FM
J Rheumatol; 1987 Apr; 14(2):278-83. PubMed ID: 3298649
[TBL] [Abstract][Full Text] [Related]
3. Nifedipine-induced fingertip vasodilation in patients with Raynaud's phenomenon.
Creager MA; Pariser KM; Winston EM; Rasmussen HM; Miller KB; Coffman JD
Am Heart J; 1984 Aug; 108(2):370-3. PubMed ID: 6380254
[TBL] [Abstract][Full Text] [Related]
4. Role of digital artery adrenoceptors in Raynaud's disease.
Cooke JP; Creager SJ; Scales KM; Ren C; Tsapatsaris NP; Beetham WP; Creager MA
Vasc Med; 1997; 2(1):1-7. PubMed ID: 9546943
[TBL] [Abstract][Full Text] [Related]
5. The peripheral vascular effects of nifedipine in Raynaud's syndrome associated with scleroderma: a double blind crossover study.
Finch MB; Dawson J; Johnston GD
Clin Rheumatol; 1986 Dec; 5(4):493-8. PubMed ID: 3816096
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Raynaud's phenomenon with calcium channel blockers.
Smith CR; Rodeheffer RJ
Am J Med; 1985 Feb; 78(2B):39-42. PubMed ID: 3976694
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
Rademaker M; Cooke ED; Almond NE; Beacham JA; Smith RE; Mant TG; Kirby JD
BMJ; 1989 Mar; 298(6673):561-4. PubMed ID: 2467711
[TBL] [Abstract][Full Text] [Related]
8. Reactive hyperemia in patients with Raynaud's phenomenon.
Russell A; Kappagoda T
J Rheumatol; 1988 Nov; 15(11):1653-7. PubMed ID: 3236299
[TBL] [Abstract][Full Text] [Related]
9. A double-blind cross-over study of nifedipine retard in patients with Raynaud's phenomenon.
Finch MB; Copeland S; Passmore AP; Johnston GD
Clin Rheumatol; 1988 Sep; 7(3):359-65. PubMed ID: 3067954
[TBL] [Abstract][Full Text] [Related]
10. Nifedipine in patients with Raynaud's syndrome--effects on radial artery blood flow.
Lewis P; Psaila JV; Morgan RH; Davies WT; Woodcock JP
Eur Heart J; 1987 Nov; 8 Suppl K():83-6. PubMed ID: 3450524
[TBL] [Abstract][Full Text] [Related]
11. A randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon.
Corbin DO; Wood DA; Macintyre CC; Housley E
Eur Heart J; 1986 Feb; 7(2):165-70. PubMed ID: 3516704
[TBL] [Abstract][Full Text] [Related]
12. Laser-Doppler flowmetry in the assessment of "mild" Raynaud's phenomenon and its treatment.
Cesarone MR; Laurora G; Smith SR; Belcaro G
Panminerva Med; 1990; 32(4):151-4. PubMed ID: 2090987
[TBL] [Abstract][Full Text] [Related]
13. Nifedipine as a therapeutic modality for Raynaud's phenomenon.
Winston EL; Pariser KM; Miller KB; Salem DN; Creager MA
Arthritis Rheum; 1983 Oct; 26(10):1177-80. PubMed ID: 6626276
[TBL] [Abstract][Full Text] [Related]
14. Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis.
Meyrick Thomas RH; Rademaker M; Grimes SM; MacKay A; Kovacs IB; Cook ED; Bowcock SM; Kirby JD
Br J Dermatol; 1987 Aug; 117(2):237-41. PubMed ID: 3307894
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
Wigley FM; Malamet R; Wise RA
J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
[TBL] [Abstract][Full Text] [Related]
16. [Study of the plethysmographic amplification factor during vasodilator treatment. Healthy subject versus primary Raynaud phenomenon].
Lasfargues G; Royere D; Perrotin D; Titon JP; Soutif D; Guilmot JL
J Mal Vasc; 1987; 12(4):319-22. PubMed ID: 3694055
[TBL] [Abstract][Full Text] [Related]
17. Slow release nifedipine in the treatment of Raynaud's phenomenon.
Costantini A; Martelli E; Bavera P; Agus GB
Int Angiol; 1987; 6(4):359-63. PubMed ID: 3330116
[TBL] [Abstract][Full Text] [Related]
18. Acute effects of sublingual nifedipine in patients with Raynaud's phenomenon.
Gush RJ; Taylor LJ; Jayson MI
J Cardiovasc Pharmacol; 1987 May; 9(5):628-31. PubMed ID: 2439846
[TBL] [Abstract][Full Text] [Related]
19. Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effects.
Kallenberg CG; Wouda AA; Kuitert JJ; Tijssen J; Wesseling H
J Rheumatol; 1987 Apr; 14(2):284-90. PubMed ID: 3598997
[TBL] [Abstract][Full Text] [Related]
20. Nifedipine in pulmonary arterial hypertension. Importance of Raynaud's phenomenon.
Fisher J; Mack RJ; Likier HM; Schiff AN; Borer JS
Chest; 1987 Sep; 92(3):400-5. PubMed ID: 3622018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
